HEK293 human embryonic kidney cells endogenously express the P2Y1 and P2Y2 receptors

Neuropharmacology

Volumn 36, Issue 9, 1997, Pages 1181-1187

  Schachter, Joel B ^a   Sromek, Susan M ^a   Nicholas, Robert A ^a   Harden, T Kendall ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

ATP; HEK293 cells; Human; P2Y1 receptor; P2Y2 receptor; Phospholipase C

Indexed keywords

2 CHLOROADENOSINE 5' TRIPHOSPHATE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; PURINE P2Y RECEPTOR; RECEPTOR SUBTYPE; URIDINE TRIPHOSPHATE;

ARTICLE; CELL METABOLISM; EMBRYO; EMBRYO CELL; HUMAN; HUMAN CELL; KIDNEY CELL; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

EID: 0030682385     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00138-X     Document Type: Review

References (32)

1. Akbar G. K. M., Dasari V. R., Webb T. E., Ayyanathan K., Pillarisetti K., Sandhu A. K., Athwal R. S., Daniel J. L., Ashby B., Barnard E. A. and Kunapuli S. P. (1996) Molecular cloning of a novel P2 purinoceptor from human erythroleukemia cells. Journal of Biological Chemistry 271: 18363-18367.
2. Berridge M. J., Dawson R. M. C., Downes C. P., Heslop J. P. and Irvine R. F. (1983) Changes in the level of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. Biochemical Journal 212: 473-482.
3. 2Y-purinergic receptor that inhibits adenylyl cyclase but does not activate phospholipase C. Journal of Pharmacology and Experimental Therapeutics 267: 1140-1146.
4. 2Y-purinergic receptors. British Journal of Pharmacology 113: 614-620.
5. Brown C., Tanna B. and Boarder M. R. (1995) PPADS: an antagonist at endothelial P2Y-purinoceptors but not P2U-purinoceptors. British Journal of Pharmacology 116: 2413-2416.
6. Brown H. A., Lazarowski E. R., Boucher R. C. and Harden T. K. (1991) Evidence that UTP and ATP regulate phospholipase C through a common extracellular 5′-nucleotide receptor in human airway epithelial cells. Molecular Pharmacology 40: 648-655.
7. 2 nucleotide receptor. Journal of Biological Chemistry 270: 26152-26158.
8. Communi D., Pirotton S., Parmentier M. and Boeynaems J.-M. (1995) Cloning and functional expression of a human uridine nucleotide receptor. Journal of Biologocal Chemistry 270: 30849-30852.
9. 6 receptor. Biochemical and Biophysical Research Communications 222: 303-308.
10. Cowen D. S., Lazarus H. M., Shurin S. B., Stoll S. E. and Dubyak G. R. (1989) Extracellular adenosine triphosphate activates calcium mobilization in human phagocytic leukocytes and neutrophil/monocyte progenitor cells. Journal of Clinical Investigation 83: 1651-1660.
11. 2Y-purinergic receptor that couples to phospholipase C. Molecular Pharmacology 46: 8-14.
12. Garritsen A., Zhang Y. and Cooper D. M. F. (1992) Purinergic receptor regulation of signal transduction in NCB-20 cells. Molecular Pharmacology 41: 743-749.
13. Hourani S. M. O. and Hall D. A. (1994) Receptors for ADP on human blood platelets. Trends in Pharmacological Science 15: 103-108.
14. Iredale P. A. and Hill S. J. (1993) Increases in intracellular calcium via activation of an endogeneous P2-purinoceptor in cultured CHO-K1 cells. British Journal of Pharmacology 110: 1305-1310.
15. 2 purinoceptor-mediated responses. European Journal of Pharmacology 217: 217-219.
16. 2U-purinergic receptor. Potent activation by diadenosine tetraphosphate. British Journal of Pharmacology 116: 1619-1627.
17. Lazarowski, E. R., Homolya, L., Boucher, R. C. and Harden, T. K. (1997) Direct demonstration of mechanically-induced release of cellular UTP and its implication for uridine nucleotide receptor activation. Journal of Biological Chemistry 272: 24348-24359.
18. Lin T. A., Lustig K. D., Sportiello M. G., Weisman G. A. and Sun G. Y. (1993) Signal transduction pathways coupled to a P2U receptor in neuroblastoma × glioma (NG108-15) cells. Journal of Neurochemistry 60: 1115-1125.
19. Lustig K. D., Shiau A. K., Brake A. J. and Julius D. (1993) Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proceedings of the National Academy of Science of the U.S.A. 90: 5113-5117.
20. Mills D. C. B. (1996) ADP receptors on platelets. Thrombosis and Hematosis 76: 835-856.
21. 2+ entry by ATP and UTP in promyelocytic leukaemia HL60 cells. Biochemical Journal 305: 879-887.
22. 2+ and cAMP levels by protein kinase C. Molecular Pharmacology 44: 1185-1191.
23. Nicholas R. A., Watt W. C., Lazarowski E. R., Li Q. and Harden T. K. (1996) The uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an adenine and uridine triphosphate-specific receptor. Molecular Pharmacology 50: 224-229.
24. 2 receptors, only one of which subserves stimulation of norepinephrine release. Cellular and Molecular Neurobiology 14: 27-47.
25. 2U nucleotide receptor, a target for cystic fibrosis pharmacology. Proceedings of the National Academy of Science of the U.S.A. 91: 3275-3279.
26. Pianet I., Merle M. and Labouesse J. (1989) ADP and, indirectly, ATP are potent inhibitors of cAMP production in intact isoproterenol-stimulated C6 glioma cells. Biochemical and Biophysical Research Communications 163: 1150-1157.
27. Ralevic V. and Burnstock G. (1996) Discrimination of PPADS between endothelial P2Y-and P2U-purinoceptors in the rat isolated mesenteric arterial bed. British Journal of Pharmacology 118: 428-434.
28. 2Y1 receptor. British Journal of Pharmacology 118: 167-173.
29. Webb T. E., Simon J., Krishek B. J., Bateson A. N., Smart T. G., King B. F., Burnstock G. and Barnard E. A. (1993) Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Letters 324: 219-225.
30. 5. Biochemical and Biophysical Research Communications 219: 105-110.
31. Yu H. and Ferner J. (1993) Osteoblast-like cells have a variable mixed population of purino/nucleotide receptors. FEBS Letters 328: 209-214.
32. Zegarra-Moran O., Romeo G. and Galietta J. L. V. (1995) Regulation of transepithelial ion transport by two different purinoceptors in the apical membrane of canine kidney (MDCK) cells. British Journal of Pharmacology 114: 1052-1056.